6975-91-3

Basic information

• Product Name: CYCLOHEXYL 2-CHLOROACETATE
• Synonyms: BUTTPARK 94\04-57;CYCLOHEXYL 2-CHLOROACETATE;CYCLOHEXYL CHLOROACETATE;1-[(Chloroacetyl)oxy]cyclohexane;Acetic acid, 2-chloro-, cyclohexyl ester;Cyclohexyl 2-Chloroacetate(WX630035)
• CAS NO: 6975-91-3
• Molecular Formula: C₈H₁₃ClO₂
• Molecular Weight: 176.64
• Mol File: 6975-91-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 102 °C
• Flash Point: 99.7°C
• Appearance: /
• Density: 1.11 g/cm³
• Vapor Pressure: 0.0775mmHg at 25°C
• Refractive Index: 1.465
• CAS DataBase Reference: CYCLOHEXYL 2-CHLOROACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: CYCLOHEXYL 2-CHLOROACETATE(6975-91-3)
• EPA Substance Registry System: CYCLOHEXYL 2-CHLOROACETATE(6975-91-3)

Safety Data

• Hazard Codes: C:Corrosive
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 6975-91-3(Hazardous Substances Data)

Usage

General Description

CYCLOHEXYL 2-CHLOROACETATE is a chemical compound that is primarily used as a reagent in organic synthesis. It is a colorless, clear liquid with a faint odor. CYCLOHEXYL 2-CHLOROACETATE is known for its versatility in various chemical reactions, and it is commonly used as an intermediate in the production of pharmaceuticals, agrochemicals, and fragrances. It is also used in the production of other chemicals such as plasticizers, pesticides, and coatings. Additionally, CYCLOHEXYL 2-CHLOROACETATE is known for its low toxicity and is considered safe for use in industrial and laboratory settings with appropriate safety precautions.

InChI:InChI=1/C8H13ClO2/c9-6-8(10)11-7-4-2-1-3-5-7/h7H,1-6H2

Upstream product

• 79-11-8 chloroacetic acid 
• 108-93-0 cyclohexanol 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 22500-00-1 β-Cyan-β-phenyl-propionsaeure-cyclohexylester 
• 22500-03-4 β-Cyan-β-phenyl-glutarsaeure-di-cyclohexylester 
• 102049-64-9 Cyclohexyloxycarbonylmethyl-triphenyl-phosphonium-chlorid 
• 65717-27-3 cyclohexyl 2-(diethoxyphosphoryl)acetate 
• 101172-22-9 cyclohexyl 2-(piperidin-1-yl)acetate 
• 65267-97-2 2,4-dichlorophenoxyacetic acid cyclohexyl ester 
• 106596-73-0 cyclohexyl phenoxyacetate 
• 79-11-8 chloroacetic acid 
• 1366067-97-1 3-tert-butoxycarbonylaminopropionic acid cyclohexyloxycarbonylmethyl ester 
• 114703-83-2 N-cyclohexyl-N-methyl-4-[2-amino-3-(cyclohexyloxycarbonylmethyl)-3,4-dihydroquinazolin-6-yl]oxybutyramide hydrobromide 
• 114703-79-6 2-(cyclohexyloxy)-2-oxoethan-1-aminium chloride 
• 114652-95-8 [4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-acetic acid cyclohexyloxycarbonylmethyl ester 
• 114653-16-6 (4-Oxiranylmethoxy-phenyl)-acetic acid cyclohexyloxycarbonylmethyl ester 
• 25344-92-7 C₃₀H₅₈N₂O₄⁽²⁺⁾*2Cl^(1-) 

Relevant articles and documents

(meth)acrylate compound

The invention relates to a (meth)acrylate compound as well as a preparation method and application thereof. The compound has the following structure shown in the specification, and the preparation method is simple. The compound has the advantages of low odor or no odor, low irritation or no irritation, low viscosity, high reactivity and moderate glass transition temperature of the obtained polymer, can participate in free radical polymerization, has favorable flexibility and adhesivity, and can be used in light-cured ink, paint and adhesives.

Electronic and steric substituent influences on the conformational equilibria of cyclohexyl esters: The anomeric effect is not anomalous!

The cyclohexyl esters of a series of carboxylic acids, RCO2H, spanning a range of electronegativities and quotients of steric hindrance for the R substituent (R = Me, Et, iPr, tBu, CF3, CH2Cl, CHCl2, CH2Br, CHBr2, and CBr3) were prepared. Their conformational equilibria in CD2Cl2 were examined by low-temperature 1H NMR spectroscopy to study the axial or equatorial orientation of the ester functionality with respect to the adopted chair conformation of the cyclohexane ring. The ab initio and DFT geometry-optimized structures and relative free energies of the axial and equatorial conformers were also calculated at the HF/ 6-311G**, MP2/6-311G, and B3LYP/ 6-31G** levels of theory, both in the gas phase and in solution. In the latter case, a self-consistent isodensity polarized continuum model was employed. Only by including electron correlation in the modeling calculations for the solvated molecules was it possible to obtain a reasonable correlation between ΔG°calcd and ΔG°exp. Both the structures and the free energy differences of the axial and equatorial conformers were evaluated with respect to the factors normally influencing conformational preference, namely, 1,3-diaxial steric interactions in the axial conformer and hyperconjugation. It was assessed that hyperconjugative interactions, σC-C/σC-H and σC-O*, together with a steric effect - the destabilization of the equatorial conformer with increasing bulk of the R group - were the determinant factors for the position of the conformational equilibria. Thus, because hyperconjugation is held responsible as the mitigating factor for the anomeric effect in 2-substituted, six-membered saturated heterocyclic rings, and since it is also similarly responsible, at least partly, in these monosubstituted cyclohexanes for a preferential shift towards the axial conformer, the question is therefore raised: can the anomeric effect really be construed as anomalous?

N-N-DISUBSTITUTED-OMEGA-(2-AMINO-3-(CARBONYLMETHYL)-3,4-DIHYDROQUINAZOLINYL)OXY-ALKYLAMIDES AND RELATED COMPOUNDS

Compounds are disclosed according to the formula or an optical isomer thereof. The compounds of formula I are cyclic AMP phosphodiesterase inhibitors useful as antithrombotic and inotropic agents and the like in mammals